Works matching IS 00278874 AND DT 2011 AND VI 103 AND IP 20
Results: 28
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1529, doi. 10.1093/jnci/djr351
- By:
- Publication type:
- Article
Cautious Optimism for Proposed European MRI Exposure Limit Exemption.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1495, doi. 10.1093/jnci/djr413
- By:
- Publication type:
- Article
International Cancer Conference: Targeted Therapies Boom Expected in 3–5 Years.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
Molecular Characterization of the Tumor-Suppressive Function of Nischarin in Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1513, doi. 10.1093/jnci/djr350
- By:
- Publication type:
- Article
Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1540
- By:
- Publication type:
- Article
Enthusiasm for Antibody–Drug Conjugates.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1493, doi. 10.1093/jnci/djr422
- By:
- Publication type:
- Article
Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1557, doi. 10.1093/jnci/djr328
- By:
- Publication type:
- Article
mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1552, doi. 10.1093/jnci/djr326
- By:
- Publication type:
- Article
Company Stock Prices Before and After Public Announcements Related to Oncology Drugs.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1507, doi. 10.1093/jnci/djr338
- By:
- Publication type:
- Article
Re: Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1558, doi. 10.1093/jnci/djr327
- By:
- Publication type:
- Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY.
- Published in:
- 2011
- Publication type:
- Table of Contents
TABLE OF CONTENTS.
- Published in:
- 2011
- Publication type:
- Table of Contents
StatBite Number of MRI units per million population, 2010.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1496, doi. 10.1093/jnci/djr425
- Publication type:
- Article
Response: Re: Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1559, doi. 10.1093/jnci/djr332
- By:
- Publication type:
- Article
Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1498
- By:
- Publication type:
- Article
Oncology Micro-Cap Stocks: Caveat Emptor!
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1488, doi. 10.1093/jnci/djr375
- By:
- Publication type:
- Article
Antimalaria Drug Offers Antitumor Strategies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1490, doi. 10.1093/jnci/djr423
- By:
- Publication type:
- Article
EDITORIAL BOARD.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. NP, doi. 10.1093/jnci/djr434
- Publication type:
- Article
Survival Disparities Between African-American and White Colo-rectal Cancer Patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. NP, doi. 10.1093/jnci/djr443
- Publication type:
- Article
IN THIS ISSUE.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1485, doi. 10.1093/jnci/djr415
- Publication type:
- Article
Response: Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1558, doi. 10.1093/jnci/djr329
- By:
- Publication type:
- Article
Company Stock Prices Before Public Announcements of Oncology Trial Results.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. NP, doi. 10.1093/jnci/djr429
- Publication type:
- Article
Awards, Appointments, Announcements.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 20, p. 1497, doi. 10.1093/jnci/djr412
- Publication type:
- Article
Cover.
- Published in:
- 2011
- Publication type:
- Cover Art
Race and Subset Analyses in Clinical Trials: Time to Get Serious About Data Integration.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Erratum.
- Published in:
- 2011
- Publication type:
- Correction Notice